ClinicalTrials.govpublic full text
Phase IIb Study of Intranasal Glutathione in Parkinson's Disease
parkinson's disease, reduced glutathione, intranasal, (in)gsh, glutathione, uptake, central nervous system, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 856425
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.